J Cutan Med Surg. 2014 Jul-Aug;18(4):271-4. doi: 10.2310/7750.2013.13116.
We report two cases of mosaic generalized neurofibromatosis 1 (NF1) and review the history of the classification of segmental neurofibromatosis (SNF; Ricardi type NF-V). Somatic mutations giving rise to limited disease, such as segmental neurofibromatosis are manifestations of mosaicism. If the mutation occurs before tissue differentiation, the clinical phenotype will be generalized disease. Mutations that occur later in development give rise to disease that is confined to a single region.
Segmental neurofibromatosis is caused by a somatic mutation of neurofibromatosis type 1, and should not be regarded as a distinct entity from neurofibromatosis 1. Cases previously referred to as unilateral or bilateral segmental neurofibromatosis are now best referred to as mosaic generalized or mosaic localized neurofibromatosis 1.
我们报告了两例镶嵌型泛发性神经纤维瘤病 1 型(NF1)病例,并回顾了节段性神经纤维瘤病(SNF;Ricardi 型 NF-V)的分类历史。导致局限性疾病的体细胞突变,如节段性神经纤维瘤病,是镶嵌现象的表现。如果突变发生在组织分化之前,则临床表型将为泛发性疾病。在发育后期发生的突变会导致局限于单个区域的疾病。
节段性神经纤维瘤病是由 NF1 的体细胞突变引起的,不应将其视为与神经纤维瘤病 1 不同的实体。以前被称为单侧或双侧节段性神经纤维瘤病的病例,现在最好被称为镶嵌型泛发性或镶嵌型局限性神经纤维瘤病 1。